Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
Debt to Equity Over TimeFair Value
Percentile Rank14
3Y CAGR-10.1%
5Y CAGR-18.8%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-10.1%/yr
vs +10.2%/yr prior
5Y CAGR
-18.8%/yr
Recent acceleration
Acceleration
-20.3pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
5 yr
Consecutive declineFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.09 | -6.0% |
| 2024 | 0.09 | -11.5% |
| 2023 | 0.10 | -12.7% |
| 2022 | 0.12 | -17.1% |
| 2021 | 0.14 | -41.2% |
| 2020 | 0.24 | +279.8% |
| 2019 | 0.06 | -20.4% |
| 2018 | 0.08 | -29.3% |
| 2017 | 0.11 | +5.9% |
| 2016 | 0.11 | - |